Experiencing premature ejaculation (PE) can feel like a battle against your own body, leading to feelings of defeat and disconnection. Many individuals find themselves cycling through ineffective treatments. However, new technology-based solutions are emerging, offering hope for a drug-free, on-demand alternative. Research highlighted in a 2024 study published in IJIR: Your Sexual Medicine Journal explores how these innovations may help delay ejaculation, providing a potential improvement in sexual health and quality of life.
Understanding Premature Ejaculation
The International Society for Sexual Medicine (ISSM) defines PE through three main criteria:
- Rapid ejaculation following vaginal penetration.
- Consistent inability to delay ejaculation during most sexual encounters.
- Resulting personal distress, frustration, or avoidance of intimacy.
Lifelong PE typically starts with one’s first sexual experience, with ejaculation occurring within a minute. Acquired PE develops after a period of normal ejaculation, usually within three minutes. This definition primarily applies to heterosexual encounters, with limited guidance for anal or same-sex contexts.
The prevalence of PE is difficult to gauge due to its self-reported nature and the emphasis on personal distress rather than medical symptoms. While older studies suggested a prevalence of 20-30%, recent research indicates it might be closer to 5%.
Causes and Traditional Treatments
The causes of PE are not fully understood. Lifelong PE is thought to be linked to changes in brain chemicals, increased penile sensitivity, erectile issues, genetic factors, hormone imbalances, and prostate problems. Acquired PE often relates to medical, psychological, or relationship issues.
Traditional treatments include topical anesthetics, antidepressants, and behavioral therapy. These may provide temporary relief, but PE often returns after discontinuation. Topical anesthetics, though widely used, have a low satisfaction rate, with only 10% of men continuing their use. Antidepressants like SSRIs may delay ejaculation by increasing serotonin levels, but many men discontinue due to limited effectiveness. Behavioral therapy can build confidence and reduce anxiety, helping 45-65% of men short-term, though long-term success is uncertain.
Emerging Tech-Based Solutions
Dr. Ilan Gruenwald and Dr. Arik Shechter have explored new research-backed technologies for PE treatment. One promising method is transcutaneous electrical nerve stimulation (TENS) applied to the pelvic floor muscles, which may extend ejaculation time.
A 2017 study by Shechter and colleagues involved TENS on the perineal area of 23 men with lifelong PE, showing significant increases in ejaculation time. Building on these results, a miniaturized on-demand TENS device, the In2 patch®, was developed. A 2019-2020 study found that it significantly improved ejaculation time among 59 men with lifelong PE, with no serious side effects reported.
Another technique is transcutaneous posterior tibial nerve stimulation (TPTNS), targeting nerves involved in semen release. In a small phase II trial, 54% of participants experienced a threefold increase in ejaculation time with minimal side effects. A subsequent trial showed modest gains, with placebo effects possibly due to probe contact sensations.
Innovative Physical Tools
Researchers are also investigating physical tools that retrain the arousal response. The Myhixel® device, a masturbation aid, pairs with behavioral training to reduce sensitivity and simulate intercourse. In a clinical trial, 52 men completed an eight-week program, half using the Myhixel® device, indicating its potential as part of a comprehensive PE management strategy.
Conclusion
Tech-based treatments are paving the way for innovative and effective options for those dealing with premature ejaculation. While further research is needed, these new approaches offer hope for long-term management and improved sexual well-being.